Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Clinical Genitourinary Cancer|September 13, 2025
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter StudyF Mastroleo, R Villa, M Zaffaroni, et al.
Life (Basel, Switzerland)|July 27, 2024
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve PatientsRiccardo Santamaria, Mattia Zaffaroni, Maria Giulia Vincini, et al.
Scientific Reports|October 31, 2025
Real-world survival and prognostic factors in WHO 2021 classified gliomas treated with chemo-radiotherapyMateusz Bilski, Georges Noël, Krzysztof Smółka, et al.
Iscience|August 28, 2023
Enhancing European capabilities for application of multi-omics studies in biology and biomedicine space researchAránzazu Manzano, Silvio Weging, Daniela Bezdan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2026
Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysisMarcin Miszczyk, Nishan Sohoni, Shayan Smani, et al.
Clinical Nuclear Medicine|May 4, 2026
Outcomes of Radiotherapy With or Without Dose Escalation to Lymph Node Metastases Detected by PET PSMA or Conventional Imaging in Node-Positive Prostate Cancer: A Real-World Multicenter Propensity Score-Matched (PRIMENOD) AnalysisMateusz Bilski, Federico Mastroleo, Artur J Chyrek, et al.
BMC Cancer|December 15, 2023
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN studyStefania Volpe, Mattia Zaffaroni, Gaia Piperno, et al.
NPJ Breast Cancer|August 23, 2022
ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistanceAntonio Strillacci, Pasquale Sansone, Vinagolu K Rajasekhar, et al.
European Radiology|March 20, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning modelsGiulia Marvaso, Lars Johannes Isaksson, Mattia Zaffaroni, et al.
Critical Reviews in Oncology/Hematology|September 5, 2024
The emerging role of Artificial Intelligence in proton therapy: A reviewLars Johannes Isaksson, Federico Mastroleo, Maria Giulia Vincini, et al.
Pageof 22